| Literature DB >> 23424362 |
Wendy Tsai1, Stanford Erickson.
Abstract
The promise of start-up biotechnology companies is enormous. So are the risks and the uncertainty of product development. The authors present a checklist for young biotech companies, covering environmental factors, alliances, and strategic planning.Year: 2006 PMID： 23424362 PMCID： PMC3571061
Source DB: PubMed Journal: Biotechnol Healthc ISSN： 1554-169X